Table of Contents Table of Contents
Previous Page  204-205 / 427 Next Page
Information
Show Menu
Previous Page 204-205 / 427 Next Page
Page Background

Analytical Challenges

Number of potential synthetic PDE5 inhibitors:

th 100 k

l

more an 

 nown ana ogs

more than 50 analogs reported as adulterants

Availability of reference standards

Inventiveness of adulterators:

exotic analogs

mixtures of analogs

embedding of adulterants into capsule walls

Complex and variable dietary supplement matrices